Physician profile
Erin E Dugan
NPI 1285979146
$2,225.06
in general payments reported to CMS, 2019-2025
11 companies · $494 in 2025
The $494 reported for 2025 was more than what 76% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.11 · 2022: $602 · 2023: $701 · 2024: $411 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $562.88 | 2022-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $333.89 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Scpharmaceuticals INC. | $285.43 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.32 | 2022-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $201.41 | 2022-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $164.73 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $151.85 | 2022-2025 | Farxiga, Lokelma, Brilinta |
| Pfizer INC. | $136.89 | 2022-2025 | |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Alnylam Pharmaceuticals INC. | $24.91 | 2025 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $0.75 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Dugan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.